References
- Akkari H, Belhadjali H, Youssef M, et al. Baboon syndrome induced by hydroxyzine. Indian J Dermatol 2013;58:244
- Hausermann P, Bircher AJ. SDRIFE – another acronym for a distinct cutaneous drug exanthema: do we really need it?. Dermatology 2007;214:1–2
- Andersen KE, Hjorth N, Menné T. The baboon syndrome: systemically-induced allergic contact dermatitis. Contact Dermatitis 1984;10:97–100
- Häusermann P, Harr T, Bircher AJ. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome?. Contact Dermatitis 2004;51:297–310
- Miyahara A, Kawashima H, Okubo Y, Hoshika A. A new proposal for a clinical-oriented subclassification of baboon syndrome and a review of baboon syndrome. Asian Pac J Allergy Immunol 2011;29:150–160
- Lerch M, Bircher AJ. Systemically induced allergic exanthema from mercury. Contact Dermatitis 2004;50:349–353
- Sikar Aktürk A, Bayramgürler D, Salman S, et al. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by oral metronidazole. Cutan Ocul Toxicol 2014;33:337–338
- Barbaud A, Tréchot P, Granel F, et al. A baboon syndrome induced by intravenous human immunoglobulins: report of a case and immunological analysis. Dermatology 1999;199:258–260
- Winnicki M, Shear HN. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE) a closer look at these conditions and an approach to intertriginous eruptions. Am J Clin Dermatol 2011;12:171–180
- Elmariah SB, Cheung W, Wang N, et al. Systemic drug-related intertriginous and flexural exanthema (SDRIFE). Dermatol Online J 2009;15:3